Thomas Hermann Selected Research

Thomas Hermann Research Topics

2	Neoplasms (Cancer) 12/2012 - 03/2007
2	Insulin Resistance 11/2004 - 10/2003
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Overweight 03/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019
1	Human Influenza (Influenza) 11/2016
1	Hepatitis C 04/2008
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2007
1	Lung Neoplasms (Lung Cancer) 03/2007
1	Body Weight (Weight, Body) 12/2005
1	Escherichia coli Infections 12/2005
1	Obesity 11/2004
1	Infertility (Sterility) 09/2003

2	RNA (Ribonucleic Acid)IBA 11/2016 - 04/2008
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2020
1	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2019
1	DiamondIBA 01/2019
1	ElementsIBA 04/2008
1	Internal Ribosome Entry SitesIBA 04/2008
1	Cyclin D3IBA 03/2007
1	Bexarotene (LGD1069)FDA Link 03/2007
1	Biomarkers (Surrogate Marker)IBA 03/2007
1	Cyclin D1IBA 03/2007
1	RetinoidsIBA 03/2007
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2005
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2003
1	Amino Acids FDA Link 09/2003

1	Glycemic Control 01/2020
1	Drug Therapy (Chemotherapy) 12/2012
1	Intravenous Administration 12/2005